Venue | Press Room | Subscribe | Site Map
TechConnect Summit 2006
Home | About the Summit | Program | Advisory Boards | About TechConnect

Producing Sponsor

TechConnect

Platinum Sponsor

Welsh & Katz, Ltd.

Gold Sponsor

ISTC International Science & Technology Center

Ventures Enabling Sponsor

Atomic Venture Partners

Press Sponsor

Business Wire

Partnering Sponsor

NSTI

Supporting Organizations

Boston University
Midwest Research University Network

Media Sponsors

(joint with Nanotech 2006) Nature
Science
R&D Magazine

Summit News

Event Contact

Jennifer Rocha
955 Massachusetts Ave. #313
Cambridge, MA 02139
Phone: (774) 249-8514

NanoBioMagnetics, Inc (NBMI)

Location:OK, US
Speaker:Charles Seeney
Title:President & CEO
Primary Industry:Nanobiotechnology
Executive Summary:NanoBioMagnetics, Inc. (NBMI) is a development stage nanobiomaterials company pioneering an emerging area of nanomedicine referred to as organ-assisting-device (OAD) technologies. The company’s core technology is based on an electromagnetic methodology for the site-specific placement of designed constructs of magnetically responsive nanoparticles (MNP) in driving a desired physiological event. Based on a proprietary nanofabrication platform, proprietary application platforms under development include: (1) Biostable Implant Devices, in which implanted MNP drive tissue movements in an oscillating magnetic field, and (2) Vectored Drug Delivery, in which MNP constructs, carrying a therapeutic load, are magnetically vectored to the site of therapeutic need. NBMI’s OAD technologies, site-specific and organ-specific in function, are viewed as enabling technologies that will enhance and expand the range of therapeutic options over a spectrum of human health disorders. Several OAD applications, in scientific firsts, have been experimentally validated and are being advanced through collaborations with major institutions that bring together multi-disciplinary, world-class science teams with the skills necessary for nanobioconvergence. NBMI is seeking investors and commercialization partners to support and advance the company’s OAD technologies and transition the company from a science organization to a functional business unit.
Venture is:Seed Level

 

Home | About the Summit | Program | Advisory Boards | About TechConnect
Terms of use | Privacy policy | Contact | TechConnect Home
© 2005 TechConnect. All rights reserved.